NYC SPRING
ONCOLOGY Investor

Conference

March 31 - April 1, 2020
IMPORTANT - TECHNICAL DETAILS OF HOW TO MANAGE OUR VIRTUAL PROCESS

We are excited to host you at the first virtual meeting of the Oncology Investor Conference Series, running 9:00AM EST (NYC time) through 6:30PM EST, Tuesday, March 31 and 8:30AM EST (NYC time) through 6:30PM EST on Wednesday, April 1.

We encourage you to engage in partnering NOW, through 4PM EST on Monday, March 30.  At that point, partnering will be closed, meaning 1) new meetings cannot be scheduled and 2) existing meetings cannot be cancelled, or rescheduled to another time.  

 

ACCESSING THE LIVE STREAM OF THE CONFERENCE (KEYNOTE TALKS AND COMPANY PRESENTATIONS)

All company presentations and keynote talks will be live broadcast over a Premier, private, and secure Zoom conference account, once again, running 9:00AM EST (NYC time) through 6:30PM EST, Tuesday, March 31 and 8:30AM EST (NYC time) through 6:30PM EST on Wednesday, April 1.  The agenda is available on the conference website.  The link to the secured Zoom livestream has been emailed to each investor and company.  There is ONE (1) link that all investors use and share.  Each keynote speaker and company presenter will receive their own, unique, individual link.  

You must take a minute to register your name and email address, before you can access the stream the day of, as a security measure. 

For Presenters: This VIDEO shows you the entire process you will need to know to Present Your Company or Give a Key Note Address.

 

VIRTUAL PARTNERING MECHANICS AND PROCESS

The logistics of scheduling a virtual channel/room to meet at during the event will be handled by the Jujama system.  The Jujama scheduling system can be accessed at: https://connect.jujama.com/NYC-Spring-2020-Oncology-Investor-Conference

Partnering will be suspended after 4PM EST on Monday, March 30 through Wednesday night.  Between these times, new meetings may not be scheduled, and existing meetings may not be rescheduled.  On Thursday, the partnering system will be reopened, allowing participants to send their direct contact information, if they choose to partner outside the conference.   As of 3/29, we are proud to report 142 registered meetings.

 

On Monday afternoon and evening, our team will place a link to the virtual meeting room in the stated location for each meeting in the Jujama system.  By Tuesday morning, you will see these locations in the location field for each of your meetings.  A video explaining how to find the virtual location in Jujama will be posted on the front page of the conference website, HERE, tomorrow by noon.  You will also receive a meeting invite to the virtual conference room Monday evening to your email, such that the meeting link will be added to your electronic calendaring system.  Please note that meetings will begin exactly when scheduled, and our meeting system will cut the meeting off, at exactly the scheduled end of the meeting.  A conference moderator will be on the line to help facilitate the connection and resolve any technical issues.   PLEASE BE TIMELY.  

 

Once again, thank you for participating in the event, and please engage in active partnering  through Monday, 4PM EST.  Check for meeting requests, and request meetings of companies and/or investors that are of interest to you.

TAKING PLACE
March 31 - April 1, 2020
1155 6th Ave, New York City

Access the
Partnering System

partnering.png
80+ Investors
40+ Presenting companies
5 Keynotes
Partnering System
Networking Reception
One-on-one Meetings
ABOUT THE NEW YORK ONCOLOGY INVESTOR CONFERENCE 

 

The Spring Meeting of the Oncology Investor Conference Series will be held on March 31 and April 1, 2020. The National Foundation for Cancer Research and Perkins Coie are the presenting sponsors and organizers. Other sponsors include Cooley Law Firm, McDermitt, Will & Emery, Venable law firm, Altru Institute, Torreya Partners and Marcum.

 

Join the leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, startup public and private cancer companies and cancer foundations for a discussion on trends, opportunities and risks in oncology investing. The conference will feature corporate presentations by a select group of public and private oncology companies, and updates on cutting edge science.  

80+ Investors  40+ Presenting Companies.  4 Informative Panels.  2 Keynotes.  Networking Reception.   Partnering System.  One-on-one Meeting Space.

 
SCREENED INVESTORS
Complimentary

All Investors are Screened & Must Be Approved in Advance.

PRESENTING COMPANIES
Presentation Fee

All Presenters are Screened.  

SERVICE
PROVIDERS
Not Admitted

 

PRIOR SPEAKERS

 

CONFERENCE SERIES SPONSORS
2019-2020

Show More
immunooncology
conference
socialinvestorevent

© 2020 Oncology Investor Conference Series